Hepatic fat, not visceral fat, is associated with gallbladder polyps: A study of 2643 healthy subjects
Background and Aim Gallbladder polyps (GBPs) appear to be strongly associated with obesity and metabolic disease. To date, the relationship between GBPs and fatty liver has not been adequately evaluated. The aim of the present study was to investigate whether GBPs are associated with fatty liver, wh...
Saved in:
Published in | Journal of gastroenterology and hepatology Vol. 30; no. 4; pp. 767 - 774 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Australia
Blackwell Publishing Ltd
01.04.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background and Aim
Gallbladder polyps (GBPs) appear to be strongly associated with obesity and metabolic disease. To date, the relationship between GBPs and fatty liver has not been adequately evaluated. The aim of the present study was to investigate whether GBPs are associated with fatty liver, which is an ectopic regional fat deposit, independent of visceral adipose tissue (VAT).
Methods
A cross‐sectional study using 2643 health checkup subjects (961 patients with GBP and 1682 age‐ and sex‐matched healthy controls) was conducted. The subjects underwent various laboratory tests, abdominal fat computed tomography (CT), and hepatic ultrasonography.
Results
The mean age of the subjects was 51.4 ± 8.3 years, and 74.1% were male. GBPs were significantly associated with fatty liver. Multivariate regression analysis revealed that GBPs were significantly associated with the presence of fatty liver (odds ratio [OR] 1.23, 95% confidence interval [CI]: 1.02–1.48), and adjusting for the homeostatic metabolic assessment index had little effect on this association (OR 1.23, 95% CI: 1.02–1.48). Additionally, GBPs remained significantly associated with the presence of fatty liver after adjustments for CT‐measured VAT and subcutaneous adipose tissue (OR 1.24, 95% CI: 1.03–1.50). The degree of fatty liver showed an independent (OR 1.37 95% CI: 1.03–1.80) and dose‐dependent relationship (moderate‐severe fatty liver: OR 1.55 95% CI: 1.07–2.23, P for trend = 0.014) with large GBPs (≥ 5 mm).
Conclusion
Fatty liver, an ectopic regional fat deposit, was found to be closely associated with GBPs independent of known metabolic risk factors, insulin resistance, and CT‐measured VAT, confirming a relevant clinical relationship between the two diseases. |
---|---|
AbstractList | Gallbladder polyps (GBPs) appear to be strongly associated with obesity and metabolic disease. To date, the relationship between GBPs and fatty liver has not been adequately evaluated. The aim of the present study was to investigate whether GBPs are associated with fatty liver, which is an ectopic regional fat deposit, independent of visceral adipose tissue (VAT).BACKGROUND AND AIMGallbladder polyps (GBPs) appear to be strongly associated with obesity and metabolic disease. To date, the relationship between GBPs and fatty liver has not been adequately evaluated. The aim of the present study was to investigate whether GBPs are associated with fatty liver, which is an ectopic regional fat deposit, independent of visceral adipose tissue (VAT).A cross-sectional study using 2643 health checkup subjects (961 patients with GBP and 1682 age- and sex-matched healthy controls) was conducted. The subjects underwent various laboratory tests, abdominal fat computed tomography (CT), and hepatic ultrasonography.METHODSA cross-sectional study using 2643 health checkup subjects (961 patients with GBP and 1682 age- and sex-matched healthy controls) was conducted. The subjects underwent various laboratory tests, abdominal fat computed tomography (CT), and hepatic ultrasonography.The mean age of the subjects was 51.4 ± 8.3 years, and 74.1% were male. GBPs were significantly associated with fatty liver. Multivariate regression analysis revealed that GBPs were significantly associated with the presence of fatty liver (odds ratio [OR] 1.23, 95% confidence interval [CI]: 1.02-1.48), and adjusting for the homeostatic metabolic assessment index had little effect on this association (OR 1.23, 95% CI: 1.02-1.48). Additionally, GBPs remained significantly associated with the presence of fatty liver after adjustments for CT-measured VAT and subcutaneous adipose tissue (OR 1.24, 95% CI: 1.03-1.50). The degree of fatty liver showed an independent (OR 1.37 95% CI: 1.03-1.80) and dose-dependent relationship (moderate-severe fatty liver: OR 1.55 95% CI: 1.07-2.23, P for trend = 0.014) with large GBPs (≥ 5 mm).RESULTSThe mean age of the subjects was 51.4 ± 8.3 years, and 74.1% were male. GBPs were significantly associated with fatty liver. Multivariate regression analysis revealed that GBPs were significantly associated with the presence of fatty liver (odds ratio [OR] 1.23, 95% confidence interval [CI]: 1.02-1.48), and adjusting for the homeostatic metabolic assessment index had little effect on this association (OR 1.23, 95% CI: 1.02-1.48). Additionally, GBPs remained significantly associated with the presence of fatty liver after adjustments for CT-measured VAT and subcutaneous adipose tissue (OR 1.24, 95% CI: 1.03-1.50). The degree of fatty liver showed an independent (OR 1.37 95% CI: 1.03-1.80) and dose-dependent relationship (moderate-severe fatty liver: OR 1.55 95% CI: 1.07-2.23, P for trend = 0.014) with large GBPs (≥ 5 mm).Fatty liver, an ectopic regional fat deposit, was found to be closely associated with GBPs independent of known metabolic risk factors, insulin resistance, and CT-measured VAT, confirming a relevant clinical relationship between the two diseases.CONCLUSIONFatty liver, an ectopic regional fat deposit, was found to be closely associated with GBPs independent of known metabolic risk factors, insulin resistance, and CT-measured VAT, confirming a relevant clinical relationship between the two diseases. Gallbladder polyps (GBPs) appear to be strongly associated with obesity and metabolic disease. To date, the relationship between GBPs and fatty liver has not been adequately evaluated. The aim of the present study was to investigate whether GBPs are associated with fatty liver, which is an ectopic regional fat deposit, independent of visceral adipose tissue (VAT). A cross-sectional study using 2643 health checkup subjects (961 patients with GBP and 1682 age- and sex-matched healthy controls) was conducted. The subjects underwent various laboratory tests, abdominal fat computed tomography (CT), and hepatic ultrasonography. The mean age of the subjects was 51.4 ± 8.3 years, and 74.1% were male. GBPs were significantly associated with fatty liver. Multivariate regression analysis revealed that GBPs were significantly associated with the presence of fatty liver (odds ratio [OR] 1.23, 95% confidence interval [CI]: 1.02-1.48), and adjusting for the homeostatic metabolic assessment index had little effect on this association (OR 1.23, 95% CI: 1.02-1.48). Additionally, GBPs remained significantly associated with the presence of fatty liver after adjustments for CT-measured VAT and subcutaneous adipose tissue (OR 1.24, 95% CI: 1.03-1.50). The degree of fatty liver showed an independent (OR 1.37 95% CI: 1.03-1.80) and dose-dependent relationship (moderate-severe fatty liver: OR 1.55 95% CI: 1.07-2.23, P for trend = 0.014) with large GBPs (≥ 5 mm). Fatty liver, an ectopic regional fat deposit, was found to be closely associated with GBPs independent of known metabolic risk factors, insulin resistance, and CT-measured VAT, confirming a relevant clinical relationship between the two diseases. Background and Aim Gallbladder polyps (GBPs) appear to be strongly associated with obesity and metabolic disease. To date, the relationship between GBPs and fatty liver has not been adequately evaluated. The aim of the present study was to investigate whether GBPs are associated with fatty liver, which is an ectopic regional fat deposit, independent of visceral adipose tissue (VAT). Methods A cross‐sectional study using 2643 health checkup subjects (961 patients with GBP and 1682 age‐ and sex‐matched healthy controls) was conducted. The subjects underwent various laboratory tests, abdominal fat computed tomography (CT), and hepatic ultrasonography. Results The mean age of the subjects was 51.4 ± 8.3 years, and 74.1% were male. GBPs were significantly associated with fatty liver. Multivariate regression analysis revealed that GBPs were significantly associated with the presence of fatty liver (odds ratio [OR] 1.23, 95% confidence interval [CI]: 1.02–1.48), and adjusting for the homeostatic metabolic assessment index had little effect on this association (OR 1.23, 95% CI: 1.02–1.48). Additionally, GBPs remained significantly associated with the presence of fatty liver after adjustments for CT‐measured VAT and subcutaneous adipose tissue (OR 1.24, 95% CI: 1.03–1.50). The degree of fatty liver showed an independent (OR 1.37 95% CI: 1.03–1.80) and dose‐dependent relationship (moderate‐severe fatty liver: OR 1.55 95% CI: 1.07–2.23, P for trend = 0.014) with large GBPs (≥ 5 mm). Conclusion Fatty liver, an ectopic regional fat deposit, was found to be closely associated with GBPs independent of known metabolic risk factors, insulin resistance, and CT‐measured VAT, confirming a relevant clinical relationship between the two diseases. |
Author | Lim, Seon Hee Yim, Jeong Yun Kim, Donghee Kim, Joo Sung Song, Ji Hyun Kang, Jin Hwa Cho, Sang-Heon Chung, Su Jin Yang, Sun Young |
Author_xml | – sequence: 1 givenname: Seon Hee surname: Lim fullname: Lim, Seon Hee organization: Department of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, South Korea – sequence: 2 givenname: Donghee surname: Kim fullname: Kim, Donghee email: messmd@chol.com organization: Department of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, South Korea – sequence: 3 givenname: Jin Hwa surname: Kang fullname: Kang, Jin Hwa organization: Department of Radiology, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, South Korea – sequence: 4 givenname: Ji Hyun surname: Song fullname: Song, Ji Hyun organization: Department of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, South Korea – sequence: 5 givenname: Sun Young surname: Yang fullname: Yang, Sun Young organization: Department of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, South Korea – sequence: 6 givenname: Jeong Yun surname: Yim fullname: Yim, Jeong Yun organization: Department of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, South Korea – sequence: 7 givenname: Su Jin surname: Chung fullname: Chung, Su Jin organization: Department of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, South Korea – sequence: 8 givenname: Joo Sung surname: Kim fullname: Kim, Joo Sung organization: Department of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, South Korea – sequence: 9 givenname: Sang-Heon surname: Cho fullname: Cho, Sang-Heon organization: Department of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, South Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25376159$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kM1u1DAURi1URKcDC14AeQkSaf2XOGFXRTBD1RaEQF1aN47T8eCJU9uh5O1JO20XSHAl60rW-a70nSN00PveIPSakmM6z8n2enNMWSnoM7SgQpCMSlEcoAUpaZ5VnFaH6CjGLSFEEJm_QIcs57KgebVA3doMkKzGHaT3uPcJ_7JRmwBu_2Mjhhi9tpBMi29t2uBrcK5x0LYm4MG7aYgf8CmOaWwn7DvMCsHxxoBLmwnHsdkaneJL9LwDF82rh71EPz59_F6vs_Mvq8_16XmmecFp1pjOyFYDkSUjFeMlmLkKlRIK0oiqLYAIXYLkbG4AICUzomENa0EKzTvGl-jt_u4Q_M1oYlK7uzrOQW_8GBUtCiEEJ_NbojcP6NjsTKuGYHcQJvXoZgbe7QEdfIzBdE8IJerOu5q9q3vvM3vyF6ttmr36PgWw7n-JW-vM9O_T6my1fkxk-4SNyfx-SkD4qQrJZa6uLleqruqaXH39pi74H0NboT8 |
CitedBy_id | crossref_primary_10_1097_MD_0000000000029643 crossref_primary_10_17116_terarkh2017891128_133 crossref_primary_10_3748_wjg_v26_i44_6979 crossref_primary_10_1016_j_hbpd_2024_01_006 crossref_primary_10_1097_MEG_0000000000001814 crossref_primary_10_21518_2079_701X_2022_16_14_70_78 crossref_primary_10_1016_j_asjsur_2019_03_015 crossref_primary_10_1097_CM9_0000000000003019 crossref_primary_10_22141_2224_0721_17_3_2021_232650 crossref_primary_10_1186_s12944_021_01452_6 crossref_primary_10_2147_IJGM_S399812 crossref_primary_10_1038_s41598_024_73429_1 crossref_primary_10_3389_fmed_2022_865458 crossref_primary_10_1186_s12957_025_03671_y crossref_primary_10_1186_s12876_018_0882_z |
Cites_doi | 10.1111/j.1440-1746.2007.05071.x 10.1056/NEJMoa021423 10.1038/ajg.2009.238 10.1016/j.dld.2010.01.021 10.3346/jkms.2013.28.6.876 10.1111/j.1365-2036.2007.03246.x 10.1002/hep.510310206 10.1016/0037-198X(91)90015-G 10.1161/CIRCULATIONAHA.106.675355 10.7863/jum.1998.17.4.207 10.1097/00004836-199609000-00021 10.1136/gut.2007.147090 10.3748/wjg.v19.i27.4393 10.2337/diabetes.52.10.2490 10.1001/archinte.165.7.777 10.1080/00365521.1990.12067104 10.1073/pnas.0904944106 10.2337/diabetes.50.8.1844 10.2337/dc08-1359 10.1007/BF00280883 10.5009/gnl.2007.1.2.138 10.2337/diacare.27.10.2444 10.1111/j.1365-2036.2011.04724.x 10.1016/S0140-6736(08)60269-X 10.1038/sj.bjc.6604616 10.2337/diabetes.49.5.749 10.1186/1471-230X-8-41 10.1053/gast.2002.36572 10.1097/00000658-200111000-00011 10.1053/jhep.2003.50161 10.1007/s00535-006-1790-5 10.3350/cmh.2013.19.4.325 10.1053/gast.2002.35354 10.1111/j.1572-0241.1999.875_d.x 10.2337/diacare.28.7.1810 10.1001/archinte.163.4.427 |
ContentType | Journal Article |
Copyright | 2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd 2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd. |
Copyright_xml | – notice: 2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd – notice: 2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd. |
DBID | BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1111/jgh.12841 |
DatabaseName | Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1440-1746 |
EndPage | 774 |
ExternalDocumentID | 25376159 10_1111_jgh_12841 JGH12841 ark_67375_WNG_C9CC0WPR_M |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Seoul National University Hospital Research Fund funderid: 042009100 (2009–4718) |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1OB 1OC 29K 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFZJQ AHBTC AHEFC AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F D-I DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DTERQ DU5 EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO KMS LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WOHZO WOQ WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 YFH ZZTAW ~IA ~WT AAHQN AAIPD AAMNL AANHP AAYCA ACRPL ACYXJ ADNMO AFWVQ ALVPJ AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c3631-befe7dca078209238ae174177a60b49d6a04c8a732253aa772e4b2b2da74c3f23 |
IEDL.DBID | DR2 |
ISSN | 0815-9319 1440-1746 |
IngestDate | Sun Aug 24 04:01:56 EDT 2025 Mon Jul 21 05:57:34 EDT 2025 Thu Apr 24 22:57:12 EDT 2025 Tue Jul 01 01:45:08 EDT 2025 Wed Jan 22 17:02:14 EST 2025 Wed Oct 30 09:53:16 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | fatty liver gallbladder polyps insulin resistance visceral fat |
Language | English |
License | 2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3631-befe7dca078209238ae174177a60b49d6a04c8a732253aa772e4b2b2da74c3f23 |
Notes | ArticleID:JGH12841 Seoul National University Hospital Research Fund - No. 042009100 (2009-4718) Table S1 Multivariate analysis of association between GBP and risk factors in terms of insulin level. istex:0ACD354B7ACAAA78D216D67920E3E662AF2B3AE0 ark:/67375/WNG-C9CC0WPR-M ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 25376159 |
PQID | 1664443044 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1664443044 pubmed_primary_25376159 crossref_primary_10_1111_jgh_12841 crossref_citationtrail_10_1111_jgh_12841 wiley_primary_10_1111_jgh_12841_JGH12841 istex_primary_ark_67375_WNG_C9CC0WPR_M |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-04 April 2015 2015-04-00 2015-Apr 20150401 |
PublicationDateYYYYMMDD | 2015-04-01 |
PublicationDate_xml | – month: 04 year: 2015 text: 2015-04 |
PublicationDecade | 2010 |
PublicationPlace | Australia |
PublicationPlace_xml | – name: Australia |
PublicationTitle | Journal of gastroenterology and hepatology |
PublicationTitleAlternate | J Gastroenterol Hepatol |
PublicationYear | 2015 |
Publisher | Blackwell Publishing Ltd |
Publisher_xml | – name: Blackwell Publishing Ltd |
References | Kratzer W, Haenle MM, Voegtle A et al. Ultrasonographically detected gallbladder polyps: a reason for concern? A seven-year follow-up study. BMC Gastroenterol. 2008; 8: 41-48. Collett JA, Allan RB, Chisholm RJ, Wilson IR, Burt MJ, Chapman BA. Gallbladder polyps: prospective study. J. Ultrasound Med. 1998; 17: 207-211. Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Aliment. Pharmacol. Ther. 2007; 25: 883-889. Mao YS, Mai YF, Li FJ et al. Prevalence and risk factors of gallbladder polypoid lesions in Chinese petrochemical employees. World J. Gastroenterol. 2013; 19: 4393-4399. Lichtenstein J. The gallbladder: what if it's not stones? Semin. Roentgenol. 1991; 26: 209-215. Hayashi Y, Liu JH, Moriguchi H et al. Prevalence of polypoid lesions of the gallbladder in urban and rural areas of Japan: comparison between 1988 and 1993. J. Clin. Gastroenterol. 1996; 23: 158-159. Jorgensen T, Jensen KH. Polyps in the gallbladder: a prevalence study. Scand. J. Gastroenterol. 1990; 25: 281-286. Kim SY, Lee HS, Lee YS et al. Prevalence and risk factors of gallbladder polyp in adults living in Daegu and Gyeongbuk provinces. Korean J. Gastroenterol. 2006; 48: 344-350. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 2003; 348: 1625-1638. Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 1705-1725. Lim SH, Kim DH, Park MJ et al. Is metabolic syndrome one of the risk factors for gallbladder polyps found by ultrasonography during health screening? Gut Liver 2007; 1: 138-144. Park Y, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome. Prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey, 1988-1994. Arch. Intern. Med. 2003; 163: 427-436. Segawa K, Arisawa T, Niwa Y et al. Prevalence of gallbladder polyps among apparently healthy Japanese: ultrasonographic study. Am. J. Gastroenterol. 1992; 87: 630-633. Fox CS, Massaro JM, Hoffmann U et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116: 39-48. Lin WR, Lin DY, Tai DI et al. Prevalence of and risk factors for gallbladder polyps detected by ultrasonography among healthy Chinese: analysis of 34 669 cases. J. Gastroenterol. Hepatol. 2008; 23: 965-969. Chung SJ, Kim D, Park MJ et al. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups. Gut 2008; 57: 1360-1365. Wagenknecht LE, Langefeld CD, Scherzinger AL et al. Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes 2003; 52: 2490-2496. Goodpaster BH, Krishnaswami S, Harris TB et al. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch. Intern. Med. 2005; 165: 777-783. Choi SY, Kim D, Kim HJ et al. The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans. Am. J. Gastroenterol. 2009; 104: 1953-1960. Eguchi Y, Eguchi T, Mizuta T et al. Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. J. Gastroenterol. 2006; 41: 462-469. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-578. Okamoto M, Okamoto H, Kitahara F et al. Ultrasonographic evidence of association of polyps and stones with gallbladder cancer. Am. J. Gastroenterol. 1999; 94: 446-450. The Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: management of nonalcoholic fatty liver disease. Clin. Mol. Hepatol. 2013; 19: 325-348. World Health Organization. Report of a WHO Consultation on Obesity: Prevention and Managing, the Global Epidemic. Geneva: World Health Organization, 2000. Cited December 2 2012. Available from URL: http://whqlibdoc.who.int/trs/WHO_TRS_894.pdf Saadeh S, Younossi ZM, Remer EM et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-750. Lim S, Park KS, Lee HK, Cho SI. Changes in the characteristics of metabolic syndrome in Korea over the period 1998-2001 as determined by Korean national health and nutrition examination surveys. Diabetes Care 2005; 28: 1810-1812. Marchesini G, Brizi M, Bianchi G et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-1850. Hsing AW, Sakoda LC, Rashid A et al. Body size and the risk of biliary tract cancer: a population-based study in China. Br. J. Cancer 2008; 99: 811-815. Shim SG, Lee KT, Lee JK et al. Prevalence and risk factors of gallbladder polyps in health screening subjects. Korean J. Med. 1999; 57: 1014-1020. Marchesini G, Bugianesi E, Forlani G et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37: 917-923. Vernon G, Baranova A, Younossi ZM. The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment. Pharmacol. Ther. 2011; 34: 274-284. Ryysy L, Hakkinen AM, Goto T et al. Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 2000; 49: 749-758. Loria P, Adinolfi LE, Bellentani S et al. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig. Liver Dis. 2010; 42: 272-282. Park EJ, Lee HS, Lee SH et al. Association between metabolic syndrome and gallbladder polyps in healthy Korean adults. J. Korean Med. Sci. 2013; 28: 876-880. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004; 27: 2444-2449. Chen CY, Lu CL, Chang FY, Lee SD. Risk factors for gallbladder polyps in the Chinese population. Am. J. Gastroenterol. 1997; 92: 2066-2068. Fabbrini E, Magkos F, Mohammed BS et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc. Natl. Acad. Sci. U S A 2009; 106: 15430-15435. Ruhl CE, Everhart JE. Association of diabetes, serum insulin, and C-peptide with gallbladder disease. Hepatology 2000; 31: 299-303. Pou KM, Massaro JM, Hoffmann U et al. Patterns of abdominal fat distribution: the Framingham Heart Study. Diabetes Care 2009; 32: 481-485. Csendes A, Burgos AM, Csendes P, Smok G, Rojas J. Late follow-up of polypoid lesions of the gallbladder smaller than 10 mm. Ann. Surg. 2001; 234: 657-660. 1985; 28 2001; 50 2013; 28 2000; 49 2004; 27 2003; 37 2008; 8 2008; 57 2008; 99 2011; 34 2005; 28 2003; 52 2013; 19 2001; 234 1998; 17 2010; 42 2006; 41 2003; 348 2007; 116 2009; 32 1990; 25 1997; 92 1991; 26 2005; 165 2000 2006; 48 2002; 123 2000; 31 1999; 57 2008; 23 1999; 94 1992; 87 2007; 1 2008; 371 2009; 104 2007; 25 1996; 23 2009; 106 2003; 163 e_1_2_6_32_1 e_1_2_6_10_1 e_1_2_6_31_1 e_1_2_6_30_1 e_1_2_6_19_1 e_1_2_6_13_1 e_1_2_6_36_1 e_1_2_6_14_1 e_1_2_6_35_1 e_1_2_6_11_1 e_1_2_6_34_1 e_1_2_6_12_1 Kim SY (e_1_2_6_17_1) 2006; 48 e_1_2_6_33_1 e_1_2_6_18_1 e_1_2_6_39_1 e_1_2_6_15_1 e_1_2_6_38_1 e_1_2_6_37_1 Segawa K (e_1_2_6_5_1) 1992; 87 Shim SG (e_1_2_6_16_1) 1999; 57 e_1_2_6_42_1 World Health Organization (e_1_2_6_22_1) 2000 e_1_2_6_43_1 e_1_2_6_21_1 e_1_2_6_20_1 e_1_2_6_41_1 e_1_2_6_40_1 Chen CY (e_1_2_6_6_1) 1997; 92 e_1_2_6_9_1 e_1_2_6_8_1 e_1_2_6_4_1 e_1_2_6_7_1 e_1_2_6_25_1 e_1_2_6_24_1 e_1_2_6_3_1 e_1_2_6_23_1 e_1_2_6_2_1 e_1_2_6_29_1 e_1_2_6_28_1 e_1_2_6_27_1 e_1_2_6_26_1 |
References_xml | – reference: Shim SG, Lee KT, Lee JK et al. Prevalence and risk factors of gallbladder polyps in health screening subjects. Korean J. Med. 1999; 57: 1014-1020. – reference: Lin WR, Lin DY, Tai DI et al. Prevalence of and risk factors for gallbladder polyps detected by ultrasonography among healthy Chinese: analysis of 34 669 cases. J. Gastroenterol. Hepatol. 2008; 23: 965-969. – reference: Wagenknecht LE, Langefeld CD, Scherzinger AL et al. Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes 2003; 52: 2490-2496. – reference: Chen CY, Lu CL, Chang FY, Lee SD. Risk factors for gallbladder polyps in the Chinese population. Am. J. Gastroenterol. 1997; 92: 2066-2068. – reference: Kim SY, Lee HS, Lee YS et al. Prevalence and risk factors of gallbladder polyp in adults living in Daegu and Gyeongbuk provinces. Korean J. Gastroenterol. 2006; 48: 344-350. – reference: Ruhl CE, Everhart JE. Association of diabetes, serum insulin, and C-peptide with gallbladder disease. Hepatology 2000; 31: 299-303. – reference: Csendes A, Burgos AM, Csendes P, Smok G, Rojas J. Late follow-up of polypoid lesions of the gallbladder smaller than 10 mm. Ann. Surg. 2001; 234: 657-660. – reference: Mao YS, Mai YF, Li FJ et al. Prevalence and risk factors of gallbladder polypoid lesions in Chinese petrochemical employees. World J. Gastroenterol. 2013; 19: 4393-4399. – reference: Loria P, Adinolfi LE, Bellentani S et al. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig. Liver Dis. 2010; 42: 272-282. – reference: Pou KM, Massaro JM, Hoffmann U et al. Patterns of abdominal fat distribution: the Framingham Heart Study. Diabetes Care 2009; 32: 481-485. – reference: Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004; 27: 2444-2449. – reference: Collett JA, Allan RB, Chisholm RJ, Wilson IR, Burt MJ, Chapman BA. Gallbladder polyps: prospective study. J. Ultrasound Med. 1998; 17: 207-211. – reference: Eguchi Y, Eguchi T, Mizuta T et al. Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. J. Gastroenterol. 2006; 41: 462-469. – reference: Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 1705-1725. – reference: Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 2003; 348: 1625-1638. – reference: Jorgensen T, Jensen KH. Polyps in the gallbladder: a prevalence study. Scand. J. Gastroenterol. 1990; 25: 281-286. – reference: Marchesini G, Brizi M, Bianchi G et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-1850. – reference: Fabbrini E, Magkos F, Mohammed BS et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc. Natl. Acad. Sci. U S A 2009; 106: 15430-15435. – reference: Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-578. – reference: Park Y, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome. Prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey, 1988-1994. Arch. Intern. Med. 2003; 163: 427-436. – reference: Saadeh S, Younossi ZM, Remer EM et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-750. – reference: Park EJ, Lee HS, Lee SH et al. Association between metabolic syndrome and gallbladder polyps in healthy Korean adults. J. Korean Med. Sci. 2013; 28: 876-880. – reference: Fox CS, Massaro JM, Hoffmann U et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116: 39-48. – reference: World Health Organization. Report of a WHO Consultation on Obesity: Prevention and Managing, the Global Epidemic. Geneva: World Health Organization, 2000. Cited December 2 2012. Available from URL: http://whqlibdoc.who.int/trs/WHO_TRS_894.pdf – reference: Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419. – reference: The Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: management of nonalcoholic fatty liver disease. Clin. Mol. Hepatol. 2013; 19: 325-348. – reference: Lichtenstein J. The gallbladder: what if it's not stones? Semin. Roentgenol. 1991; 26: 209-215. – reference: Segawa K, Arisawa T, Niwa Y et al. Prevalence of gallbladder polyps among apparently healthy Japanese: ultrasonographic study. Am. J. Gastroenterol. 1992; 87: 630-633. – reference: Ryysy L, Hakkinen AM, Goto T et al. Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 2000; 49: 749-758. – reference: Kratzer W, Haenle MM, Voegtle A et al. Ultrasonographically detected gallbladder polyps: a reason for concern? A seven-year follow-up study. BMC Gastroenterol. 2008; 8: 41-48. – reference: Hayashi Y, Liu JH, Moriguchi H et al. Prevalence of polypoid lesions of the gallbladder in urban and rural areas of Japan: comparison between 1988 and 1993. J. Clin. Gastroenterol. 1996; 23: 158-159. – reference: Chung SJ, Kim D, Park MJ et al. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups. Gut 2008; 57: 1360-1365. – reference: Lim S, Park KS, Lee HK, Cho SI. Changes in the characteristics of metabolic syndrome in Korea over the period 1998-2001 as determined by Korean national health and nutrition examination surveys. Diabetes Care 2005; 28: 1810-1812. – reference: Hsing AW, Sakoda LC, Rashid A et al. Body size and the risk of biliary tract cancer: a population-based study in China. Br. J. Cancer 2008; 99: 811-815. – reference: Okamoto M, Okamoto H, Kitahara F et al. Ultrasonographic evidence of association of polyps and stones with gallbladder cancer. Am. J. Gastroenterol. 1999; 94: 446-450. – reference: Lim SH, Kim DH, Park MJ et al. Is metabolic syndrome one of the risk factors for gallbladder polyps found by ultrasonography during health screening? Gut Liver 2007; 1: 138-144. – reference: Vernon G, Baranova A, Younossi ZM. The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment. Pharmacol. Ther. 2011; 34: 274-284. – reference: Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Aliment. Pharmacol. Ther. 2007; 25: 883-889. – reference: Goodpaster BH, Krishnaswami S, Harris TB et al. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch. Intern. Med. 2005; 165: 777-783. – reference: Choi SY, Kim D, Kim HJ et al. The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans. Am. J. Gastroenterol. 2009; 104: 1953-1960. – reference: Marchesini G, Bugianesi E, Forlani G et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37: 917-923. – volume: 28 start-page: 412 year: 1985 end-page: 419 article-title: Homeostasis model assessment: insulin resistance and beta‐cell function from fasting plasma glucose and insulin concentrations in man publication-title: Diabetologia – volume: 57 start-page: 1360 year: 2008 end-page: 1365 article-title: Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross‐sectional case‐control study of 7078 Koreans undergoing health check‐ups publication-title: Gut – volume: 348 start-page: 1625 year: 2003 end-page: 1638 article-title: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults publication-title: N. Engl. J. Med. – volume: 371 start-page: 569 year: 2008 end-page: 578 article-title: Body‐mass index and incidence of cancer: a systematic review and meta‐analysis of prospective observational studies publication-title: Lancet – volume: 57 start-page: 1014 year: 1999 end-page: 1020 article-title: Prevalence and risk factors of gallbladder polyps in health screening subjects publication-title: Korean J. Med. – volume: 8 start-page: 41 year: 2008 end-page: 48 article-title: Ultrasonographically detected gallbladder polyps: a reason for concern? A seven‐year follow‐up study publication-title: BMC Gastroenterol. – volume: 50 start-page: 1844 year: 2001 end-page: 1850 article-title: Nonalcoholic fatty liver disease: a feature of the metabolic syndrome publication-title: Diabetes – volume: 19 start-page: 4393 year: 2013 end-page: 4399 article-title: Prevalence and risk factors of gallbladder polypoid lesions in Chinese petrochemical employees publication-title: World J. Gastroenterol. – volume: 87 start-page: 630 year: 1992 end-page: 633 article-title: Prevalence of gallbladder polyps among apparently healthy Japanese: ultrasonographic study publication-title: Am. J. Gastroenterol. – volume: 27 start-page: 2444 year: 2004 end-page: 2449 article-title: Increasing prevalence of the metabolic syndrome among U.S. adults publication-title: Diabetes Care – volume: 1 start-page: 138 year: 2007 end-page: 144 article-title: Is metabolic syndrome one of the risk factors for gallbladder polyps found by ultrasonography during health screening? publication-title: Gut Liver – volume: 234 start-page: 657 year: 2001 end-page: 660 article-title: Late follow‐up of polypoid lesions of the gallbladder smaller than 10 mm publication-title: Ann. Surg. – volume: 104 start-page: 1953 year: 2009 end-page: 1960 article-title: The relation between non‐alcoholic fatty liver disease and the risk of coronary heart disease in Koreans publication-title: Am. J. Gastroenterol. – year: 2000 – volume: 17 start-page: 207 year: 1998 end-page: 211 article-title: Gallbladder polyps: prospective study publication-title: J. Ultrasound Med. – volume: 41 start-page: 462 year: 2006 end-page: 469 article-title: Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease publication-title: J. Gastroenterol. – volume: 48 start-page: 344 year: 2006 end-page: 350 article-title: Prevalence and risk factors of gallbladder polyp in adults living in Daegu and Gyeongbuk provinces publication-title: Korean J. Gastroenterol. – volume: 25 start-page: 883 year: 2007 end-page: 889 article-title: GI epidemiology: nonalcoholic fatty liver disease publication-title: Aliment. Pharmacol. Ther. – volume: 116 start-page: 39 year: 2007 end-page: 48 article-title: Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study publication-title: Circulation – volume: 49 start-page: 749 year: 2000 end-page: 758 article-title: Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients publication-title: Diabetes – volume: 123 start-page: 1705 year: 2002 end-page: 1725 article-title: AGA technical review on nonalcoholic fatty liver disease publication-title: Gastroenterology – volume: 32 start-page: 481 year: 2009 end-page: 485 article-title: Patterns of abdominal fat distribution: the Framingham Heart Study publication-title: Diabetes Care – volume: 92 start-page: 2066 year: 1997 end-page: 2068 article-title: Risk factors for gallbladder polyps in the Chinese population publication-title: Am. J. Gastroenterol. – volume: 99 start-page: 811 year: 2008 end-page: 815 article-title: Body size and the risk of biliary tract cancer: a population‐based study in China publication-title: Br. J. Cancer – volume: 42 start-page: 272 year: 2010 end-page: 282 article-title: Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee publication-title: Dig. Liver Dis. – volume: 37 start-page: 917 year: 2003 end-page: 923 article-title: Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome publication-title: Hepatology – volume: 28 start-page: 1810 year: 2005 end-page: 1812 article-title: Changes in the characteristics of metabolic syndrome in Korea over the period 1998–2001 as determined by Korean national health and nutrition examination surveys publication-title: Diabetes Care – volume: 25 start-page: 281 year: 1990 end-page: 286 article-title: Polyps in the gallbladder: a prevalence study publication-title: Scand. J. Gastroenterol. – volume: 28 start-page: 876 year: 2013 end-page: 880 article-title: Association between metabolic syndrome and gallbladder polyps in healthy Korean adults publication-title: J. Korean Med. Sci. – volume: 31 start-page: 299 year: 2000 end-page: 303 article-title: Association of diabetes, serum insulin, and C‐peptide with gallbladder disease publication-title: Hepatology – volume: 23 start-page: 965 year: 2008 end-page: 969 article-title: Prevalence of and risk factors for gallbladder polyps detected by ultrasonography among healthy Chinese: analysis of 34 669 cases publication-title: J. Gastroenterol. Hepatol. – volume: 163 start-page: 427 year: 2003 end-page: 436 article-title: The metabolic syndrome. Prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey, 1988–1994 publication-title: Arch. Intern. Med. – volume: 94 start-page: 446 year: 1999 end-page: 450 article-title: Ultrasonographic evidence of association of polyps and stones with gallbladder cancer publication-title: Am. J. Gastroenterol. – volume: 34 start-page: 274 year: 2011 end-page: 284 article-title: The epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults publication-title: Aliment. Pharmacol. Ther. – volume: 52 start-page: 2490 year: 2003 end-page: 2496 article-title: Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study publication-title: Diabetes – volume: 26 start-page: 209 year: 1991 end-page: 215 article-title: The gallbladder: what if it's not stones? publication-title: Semin. Roentgenol. – volume: 165 start-page: 777 year: 2005 end-page: 783 article-title: Obesity, regional body fat distribution, and the metabolic syndrome in older men and women publication-title: Arch. Intern. Med. – volume: 123 start-page: 745 year: 2002 end-page: 750 article-title: The utility of radiological imaging in nonalcoholic fatty liver disease publication-title: Gastroenterology – volume: 23 start-page: 158 year: 1996 end-page: 159 article-title: Prevalence of polypoid lesions of the gallbladder in urban and rural areas of Japan: comparison between 1988 and 1993 publication-title: J. Clin. Gastroenterol. – volume: 19 start-page: 325 year: 2013 end-page: 348 article-title: KASL clinical practice guidelines: management of nonalcoholic fatty liver disease publication-title: Clin. Mol. Hepatol. – volume: 106 start-page: 15430 year: 2009 end-page: 15435 article-title: Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity publication-title: Proc. Natl. Acad. Sci. U S A – volume: 92 start-page: 2066 year: 1997 ident: e_1_2_6_6_1 article-title: Risk factors for gallbladder polyps in the Chinese population publication-title: Am. J. Gastroenterol. – ident: e_1_2_6_9_1 doi: 10.1111/j.1440-1746.2007.05071.x – volume: 48 start-page: 344 year: 2006 ident: e_1_2_6_17_1 article-title: Prevalence and risk factors of gallbladder polyp in adults living in Daegu and Gyeongbuk provinces publication-title: Korean J. Gastroenterol. – ident: e_1_2_6_11_1 doi: 10.1056/NEJMoa021423 – ident: e_1_2_6_25_1 doi: 10.1038/ajg.2009.238 – ident: e_1_2_6_43_1 doi: 10.1016/j.dld.2010.01.021 – ident: e_1_2_6_29_1 doi: 10.3346/jkms.2013.28.6.876 – ident: e_1_2_6_33_1 doi: 10.1111/j.1365-2036.2007.03246.x – ident: e_1_2_6_28_1 doi: 10.1002/hep.510310206 – ident: e_1_2_6_24_1 doi: 10.1016/0037-198X(91)90015-G – ident: e_1_2_6_36_1 doi: 10.1161/CIRCULATIONAHA.106.675355 – ident: e_1_2_6_4_1 doi: 10.7863/jum.1998.17.4.207 – ident: e_1_2_6_10_1 doi: 10.1097/00004836-199609000-00021 – volume-title: Report of a WHO Consultation on Obesity: Prevention and Managing, the Global Epidemic year: 2000 ident: e_1_2_6_22_1 – ident: e_1_2_6_27_1 doi: 10.1136/gut.2007.147090 – ident: e_1_2_6_8_1 doi: 10.3748/wjg.v19.i27.4393 – ident: e_1_2_6_35_1 doi: 10.2337/diabetes.52.10.2490 – ident: e_1_2_6_37_1 doi: 10.1001/archinte.165.7.777 – ident: e_1_2_6_3_1 doi: 10.1080/00365521.1990.12067104 – ident: e_1_2_6_20_1 doi: 10.1073/pnas.0904944106 – ident: e_1_2_6_18_1 doi: 10.2337/diabetes.50.8.1844 – ident: e_1_2_6_38_1 doi: 10.2337/dc08-1359 – ident: e_1_2_6_23_1 doi: 10.1007/BF00280883 – ident: e_1_2_6_7_1 doi: 10.5009/gnl.2007.1.2.138 – ident: e_1_2_6_40_1 doi: 10.2337/diacare.27.10.2444 – ident: e_1_2_6_31_1 doi: 10.1111/j.1365-2036.2011.04724.x – ident: e_1_2_6_13_1 doi: 10.1016/S0140-6736(08)60269-X – ident: e_1_2_6_12_1 doi: 10.1038/sj.bjc.6604616 – ident: e_1_2_6_32_1 doi: 10.2337/diabetes.49.5.749 – volume: 57 start-page: 1014 year: 1999 ident: e_1_2_6_16_1 article-title: Prevalence and risk factors of gallbladder polyps in health screening subjects publication-title: Korean J. Med. – ident: e_1_2_6_2_1 doi: 10.1186/1471-230X-8-41 – ident: e_1_2_6_42_1 doi: 10.1053/gast.2002.36572 – ident: e_1_2_6_21_1 – ident: e_1_2_6_15_1 doi: 10.1097/00000658-200111000-00011 – ident: e_1_2_6_30_1 doi: 10.1053/jhep.2003.50161 – ident: e_1_2_6_34_1 doi: 10.1007/s00535-006-1790-5 – ident: e_1_2_6_19_1 doi: 10.3350/cmh.2013.19.4.325 – ident: e_1_2_6_26_1 doi: 10.1053/gast.2002.35354 – ident: e_1_2_6_14_1 doi: 10.1111/j.1572-0241.1999.875_d.x – ident: e_1_2_6_41_1 doi: 10.2337/diacare.28.7.1810 – volume: 87 start-page: 630 year: 1992 ident: e_1_2_6_5_1 article-title: Prevalence of gallbladder polyps among apparently healthy Japanese: ultrasonographic study publication-title: Am. J. Gastroenterol. – ident: e_1_2_6_39_1 doi: 10.1001/archinte.163.4.427 |
SSID | ssj0004075 |
Score | 2.2228377 |
Snippet | Background and Aim
Gallbladder polyps (GBPs) appear to be strongly associated with obesity and metabolic disease. To date, the relationship between GBPs and... Gallbladder polyps (GBPs) appear to be strongly associated with obesity and metabolic disease. To date, the relationship between GBPs and fatty liver has not... |
SourceID | proquest pubmed crossref wiley istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 767 |
SubjectTerms | Adult Cross-Sectional Studies fatty liver Fatty Liver - complications Fatty Liver - epidemiology Fatty Liver - metabolism Female Gallbladder Neoplasms - epidemiology Gallbladder Neoplasms - etiology gallbladder polyps Humans Insulin Resistance Intra-Abdominal Fat Lipid Metabolism Liver - metabolism Male Middle Aged Polyps - epidemiology Polyps - etiology Risk Factors visceral fat |
Title | Hepatic fat, not visceral fat, is associated with gallbladder polyps: A study of 2643 healthy subjects |
URI | https://api.istex.fr/ark:/67375/WNG-C9CC0WPR-M/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjgh.12841 https://www.ncbi.nlm.nih.gov/pubmed/25376159 https://www.proquest.com/docview/1664443044 |
Volume | 30 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS9xAEB_EgvSlttqP86NsSyl9aI4ku_nCJzmqh3AiUtGHwrK72VXxepFLTmr_end2k7SKBelbCJMw2Z2d-c3s7C8An2KT26CdmEAUmgVMRDSQNiwGVJtQKZlHocLTyJPDdHzCDs6SsyXY6c7CeH6IvuCGK8P5a1zgQtZ_L_LziyE6V0x9sFcLAdHxH-oo5kl2bcRLgsLaWcsq5Lp4uifvxaJnOKy_HgOa93GrCzx7q_CjU9n3m1wNF40cqt8P2Bz_85tewosWkJJdb0GvYEnP1mBl0m65r4MZa2y6VsSI5iuZVQ25uawVVrL8ncuaiHaKdUmwrEtwM19O0aXNyXU1vbXqkV3iiGxJZYgFR5T485e3pF5IrATVr-Fk79v30Thof84QKJrSKJDa6KxUwhHuWZSYC22TmyjLRBpKVpSpCJnKRYYOgwphQbxmMpZxKTKmqInpG1ieVTP9DohOkyQVxrpsyWx2GuUqzw3TtNAFDXNTDuBLN01ctczl-AONKe8zmPML7sZtAB970WtP1_GY0Gc3172EmF9hf1uW8NPDfT4qRqPw9OiYTwbwoTMG_hPHdooNyNWi5lFqcSSjIWMDeOutpH9bjAw5FiVatd1c_1sRfrA_dhcbTxfdhOcWsyW-eWgLlpv5Qm9bXNTI924B3AHzGAXW |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB5CAm0vfT-2T7WU0kO92Jb8gl7C0sRNs0sJCcmlCEmWkpDtOqy9pemvr0ay3aakUHozRjZjjWbmm_HoE8Dr2OQ2aCcmEIVmARMRDaQNiwHVJlRK5lGocDfydJaWB2znKDlag_f9XhjPDzEU3NAynL9GA8eC9O9WfnwyRu9qc58NPNHbJVR7v8ijmKfZtTEvCQq70jpeIdfH0z96KRpt4MR-vwpqXkauLvRs3YIvvdC-4-RsvGrlWP34g8_xf7_qNtzsMCnZ9IvoDqzpxV24Nu3-ut8DU2rsu1bEiPYdWdQt-XbaKCxm-TunDRGdlnVFsLJL8H--nKNXW5Lzen5h5SObxHHZktoQi48o8VswL0izklgMau7DwdaH_UkZdOczBIqmNAqkNjqrlHCcexYo5kLb_CbKMpGGkhVVKkKmcpGhz6BCWByvmYxlXImMKWpi-gDWF_VCPwKi0yRJhbFeWzKboEa5ynPDNC10QcPcVCN42-uJq468HM_QmPMhiTk-4W7eRvBqGHruGTuuGvTGKXsYIZZn2OKWJfxwts0nxWQSHn7e49MRvOxXA_-KczvHHuR61fAotVCS0ZCxETz0y2R4W4wkORYoWrGdsv8uCN_ZLt3F438f-gKul_vTXb77cfbpCdywEC7xvURPYb1drvQzC5Na-dxZw09MOwnx |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ta9QwGA9jg-EXdb7tnJtRRPxgj7ZJ2xQ_jZu3c3rHGI7tgxCSNNnGbtfj2hPnX788SVudTBC_lZKWp3nefnny5FeE3sSG2aSdmEDkmgZURCSQNi0GRJtQKcmiUMFp5PEkHR3Tg9PkdAV9aM_CeH6IruAGnuHiNTj4vDC_O_nZeR-Cq136rNE0ZGDSe0e_uKOoZ9m1KS8JcmtoDa2Qa-NpH72VjNZgXn_chTRvA1eXeYYP0LdWZt9wctlf1rKvfv5B5_ifH_UQ3W8QKd71JrSBVvTsEVofN3vuj5EZaei6VtiI-j2elTX-flEpKGX5OxcVFo2OdYGhrothN19OIaYt8LycXlvx8C52TLa4NNiiI4L9AcxrXC0llIKqJ-h4-PHrYBQ0f2cIFElJFEhtdFYo4Rj3LExkQtvVTZRlIg0lzYtUhFQxkUHEIEJYFK-pjGVciIwqYmLyFK3OypneRFinSZIKY2O2pHZ5GjHFmKGa5DonITNFD71r1cRVQ10Of9CY8m4Jc3bO3bz10Otu6Nzzddw16K3TdTdCLC6hwS1L-Mlknw_ywSA8OTzi4x561RoDv4K5nUIHcrmseJRaIElJSGkPPfNW0r0tBoocCxOt2E7XfxeEH-yP3MXzfx_6Eq0f7g35l0-Tz1vonsVviW8keoFW68VSb1uMVMsd5ws3P-UIqQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hepatic+fat%2C+not+visceral+fat%2C+is+associated+with+gallbladder+polyps%3A+A+study+of+2643+healthy+subjects&rft.jtitle=Journal+of+gastroenterology+and+hepatology&rft.au=Lim%2C+Seon+Hee&rft.au=Kim%2C+Donghee&rft.au=Kang%2C+Jin+Hwa&rft.au=Song%2C+Ji+Hyun&rft.date=2015-04-01&rft.issn=0815-9319&rft.eissn=1440-1746&rft.volume=30&rft.issue=4&rft.spage=767&rft.epage=774&rft_id=info:doi/10.1111%2Fjgh.12841&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_jgh_12841 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0815-9319&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0815-9319&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0815-9319&client=summon |